AlphaYouHV
Insider selling
Hannah Valantine sold $342K of BridgeBio Pharma, Inc. (BBIO) stock
Hannah Valantine, Dir of BridgeBio Pharma, Inc. (BBIO), sold 5,004 shares of BBIO stock worth $342K, per an SEC Form 4 filed Jun 24, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 22, 2026, 2 days before it was made public.
BBIO has moved -3.4% since the trade date, from $68.92 to $66.58 (Sep 21, 2026 close).
- Traded
- Jun 22, 2026
- Disclosed
- Jun 24, 2026
- Filing delay
- 2 days
- Price since
- -3.4%
- Role
- Dir
- Source
- SEC Form 4
More BBIO insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.